Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
cato.com

See what CB Insights has to offer

Founded Year

1988

Stage

Merger | Merged

About Cato Research

Cato Research is a provider of regulatory and clinical research services.

Cato Research Headquarter Location

Westpark Corporate Center 4364 South Alston Avenue

Durham, North Carolina, 27713,

United States

919-361-2286

Latest Cato Research News

CATO SMS Appoints Regulatory Strategy Leader

Jun 9, 2021

CATO SMS Appoints Regulatory Strategy Leader CARY, N.C. Jun 9, 2021 4:57 AM EDT CARY, N.C., June 9, 2021 /PRNewswire/ -- CATO SMS ,a global provider of specialized clinical research solutions, announced today that it has appointed Dr. Ernesto Vera-Sanchez to vice president of regulatory strategy and head of Good Practices (GxP) consulting services. Dr. Vera-Sanchez, who brings to CATO SMS nearly 20 years of global regulator and inspectorate experience, will spearhead CATO SMS' quality and safety initiatives serving the company's biopharmaceutical clients. Prior to joining CATO SMS, Dr. Vera-Sanchez achieved an accomplished career at the Ministry of Health, Spanish Agency of Medicines and Medical Devices (AEMPS), where he was promoted to positions of increasing responsibility. He recently served as head of Inspectorate of Good Clinical Practice (GCP) and Pharmacovigilance (PhV) Inspections. During his tenure, he acted as: national expert to the European Medicines Agency (EMA); designated participant in the Emergency Task Force for COVID-19 products; chair of good PhV practices for the Spanish Technical Inspections Committee; member of the GCP Inspectors and PhV Inspectors working groups for the EMA; representative of AEMPS as a member of the Spanish GCP inspectors group; member of the working group of the International Coalition of Medical Regulatory Authorities. Dr. Vera-Sanchez's involvement in industry initiatives has led to important developments, including implementing critical aspects of inspections and guiding new PhV legislation. He also is an active participant in the FDA-EMA initiative, in which he: participated in the FDA's Bioresearch Monitoring training program (BIMO); conducted sponsor, clinical site and CRO inspections accompanied by FDA investigators; engaged in joint inspections where FDA and EMA practices were harmonized. "We are pleased to welcome a highly experienced senior regulator to our organization," said Mark A. Goldberg, M.D., executive chairman, CATO SMS. "Ernesto's extensive regulatory, GCP and pharmacovigilance knowledge will help provide our customers with independent and proactive quality assurance support to minimize regulatory risk while protecting the safety and well-being of study participants." Dr. Vera-Sanchez began his career as a primary care physician and specialist in anesthesiology. He holds a medical degree and dual master's degrees in public health and management of health institutions from the Universidad Autonoma de Madrid. He also earned a philosophus doctor degree in pharmacology and therapeutics from the Universidad de Valladolid. About CATO SMSCATO SMS is a provider of specialized clinical research solutions that was formed in 2019 when Cato Research merged with SMS-oncology. With more than 30 years of experience focusing on the needs of small and emerging biopharmaceutical companies, CATO SMS effectively designs and executes studies ⁠— from strategy to approval ⁠— in complex indications and modalities across a variety of therapeutic areas with a proven center of excellence in oncology. CATO SMS' regulatory, therapeutic and operational expertise enables the company to meet goals and exceed expectations. Visit CATO-SMS.com  for more information. View original content: http://www.prnewswire.com/news-releases/cato-sms-appoints-regulatory-strategy-leader-301308636.html

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cato Research

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cato Research is included in 1 Expert Collection, including Clinical Trials Tech.

C

Clinical Trials Tech

424 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

Cato Research Patents

Cato Research has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/2/2005

6/7/2011

Fuel cells, Hydrogen technologies, Industrial gases, Energy conversion, Hydrogen production

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/2/2005

00/00/0000

Grant Date

6/7/2011

00/00/0000

Title

Subscribe to see more

Related Topics

Fuel cells, Hydrogen technologies, Industrial gases, Energy conversion, Hydrogen production

Subscribe to see more

Status

Grant

Subscribe to see more

Cato Research Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cato Research Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.